Aptorum Group Ltd APM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
4.99quote price arrow down-0.01 (-0.20%)
Volume
8,630
52 week range
1.35 - 17.49
Loading...
  • Open5.14
  • Day High5.16
  • Day Low4.90
  • Prev Close5.00
  • 52 Week High17.49
  • 52 Week High Date03/06/24
  • 52 Week Low1.35
  • 52 Week Low Date02/07/24

Key Stats

  • Market Cap27.301M
  • Shares Out5.47M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change103.79

KEY STATS

  • Open5.14
  • Day High5.16
  • Day Low4.90
  • Prev Close5.00
  • 52 Week High17.49
  • 52 Week High Date03/06/24
  • 52 Week Low1.35
  • 52 Week Low Date02/07/24
  • Market Cap27.301M
  • Shares Out5.47M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change103.79

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-5.47
  • Fwd P/E (NTM)-6.84
  • EBITDA (TTM)-8.877M
  • ROE (TTM)-13.93%
  • Revenue (TTM)431,380.004
  • Gross Margin (TTM)2.45%
  • Net Margin (TTM)-1,006.30%
  • Debt To Equity (MRQ)12.63%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aptorum Group Ltd

 

Content From Our Affiliates

Profile

MORE
Aptorum Group Limited is United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The Company's business segments include Therapeutics and Non-Therapeutics. Therapeutics segment is engaged in developing various drug molecules and certain...
Ian Huen
Chief Executive Officer, Founder, Executive Director
Darren Lui
President, Executive Director
Sabrina Khan
Chief Financial Officer
Address
17 Hanover Square
London
W1S 1BN
United Kingdom